Silo Pharma partners on intranasal PTSD treatment for FDA review
Silo Pharma, a biopharmaceutical company listed on NASDAQ (SILO), has announced a partnership with Resyca BV, a medical technology provider,…
Silo Pharma, a biopharmaceutical company listed on NASDAQ (SILO), has announced a partnership with Resyca BV, a medical technology provider,…
Silo Pharma, Inc., a biopharmaceutical company focused on developing novel treatments, has commenced a critical safety study for its lead…